PANCOLD A- acetaminophen, guaifenesin, pentoxyverine citrate, phenylpehrine hydcrochloride, chlorpheniramine maleate, caffeine anhydrous liquid 
DONGWHA PHARM. CO. LTD.

----------

PANCOLD A ORAL SOLUTION

ACTIVE INGREDIENTS

Active ingredients (in each 30 mL bottle)

PURPOSE

Pain Reliever-Fever Reducer, Expectorant, Antitussive, Nasal Decongestant, Antihistamine, Pain reliever aid

INDICATIONS & USAGE

Uses temporarily relieves these common cold symptoms:

WARNINGS SECTION

Warnings

Liver Warning: This product contains acetaminophen. Severe liver damage may occur if you take

Allergy alert: acetaminophen mat cause severe skin reactions. Symptoms may include:

If a skin reaction occurs, stop use and seek medical help right away.

DO NOT USE

Do not use

ASK A DOCTOR

Ask a doctor before use if you have

STOP USE

Stop use and ask doctor if

These could be signs of a serious condition.

PREGNANCY OR BREAST FEEDING

If pregnant or breast-feeding, ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children.

OVERDOSAGE

Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away. Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptom.

DOSAGE & ADMINISTRATION

Directions

Adults:Take 1 bottle (30mL) three times a day, 30 minutes after meal.
Children and infants:Do not administer. Ask a doctor.

STORAGE AND HANDLING

Other nformation

INACTIVE INGREDIENTS

PANCOLD A CASE (3 bottles x 30mL)

PANCOLD A 
acetaminophen, guaifenesin, pentoxyverine citrate, phenylpehrine hydcrochloride, chlorpheniramine maleate, caffeine anhydrous liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51352-189
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN80 mg  in 30 mL
PENTOXYVERINE CITRATE (UNII: 4SH0MFJ5HJ) (PENTOXYVERINE - UNII:32C726X12W) PENTOXYVERINE CITRATE15 mg  in 30 mL
ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D) ACETAMINOPHEN300 mg  in 30 mL
CHLORPHENIRAMINE MALEATE (UNII: V1Q0O9OJ9Z) (CHLORPHENIRAMINE - UNII:3U6IO1965U) CHLORPHENIRAMINE MALEATE2.5 mg  in 30 mL
CAFFEINE (UNII: 3G6A5W338E) (CAFFEINE - UNII:3G6A5W338E) CAFFEINE30 mg  in 30 mL
PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE10 mg  in 30 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CITRATE (UNII: 1Q73Q2JULR) 32.4 mg  in 30 mL
SUCRALOSE (UNII: 96K6UQ3ZD4) 10 mg  in 30 mL
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) 29 mg  in 30 mL
EDETATE DISODIUM (UNII: 7FLD91C86K) 3 mg  in 30 mL
ALCOHOL (UNII: 3K9958V90M) 0.5 mL  in 30 mL
SACCHARUM OFFICINARUM STEM FRUCTOOLIGOSACCHARIDES (UNII: 8LLD82AE3S) 7.5 g  in 30 mL
WATER (UNII: 059QF0KO0R)  
ORANGE (UNII: 5EVU04N5QU)  
LEMON (UNII: 24RS0A988O)  
Product Characteristics
Color    Score    
ShapeSize
FlavorORANGE (Light yellowish clear oral liquid with orange-lemon flavor.) Imprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:51352-189-733 in 1 CASE07/01/2023
130 mL in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:51352-189-755 in 1 CASE12/07/2023
230 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01207/01/2023
Labeler - DONGWHA PHARM. CO. LTD. (687745240)
Registrant - DONGWHA PHARM. CO. LTD. (687745240)
Establishment
NameAddressID/FEIBusiness Operations
DONGWHA PHARM. CO., LTD.687745240manufacture(51352-189)

Revised: 12/2023
Document Id: 0be75f4b-0006-4115-e063-6394a90a8929
Set id: fc8f1807-d344-ccc2-e053-6294a90a5089
Version: 13
Effective Time: 20231207
 
DONGWHA PHARM. CO. LTD.